The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis

Nuklearmedizin 2021; 60(05): 381-382
DOI: 10.1055/a-1429-2237

Case Report

The value of ⁽¹⁸⁾F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis

Wert der ¹⁸F-FDG-PET/CT in der Diagnose der Retroperitonealfibrose und Bewertung des Ansprechens auf deren Behandlung

Mehmet Tarik Tatoglu

Nuclear Medicine, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
Hatice Uslu

Nuclear Medicine, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey
Ebru Ibisoglu

Nuclear Medicine, Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey

References
1 Peisen F, Thaiss WM, Ekert K. et al Retroperitoneal Fibrosis and its Differential Diagnoses: The Role of Radiological Imaging. Roof 2020; 192 (10) 929-936 . Epub 2020 Jul 22
2 Treglia G, Mattoli MV, Bertagna F. et al Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int 2013; 33 (03) 549-555 . Epub 2012 Nov 5
3 Yilmaz S, Tan YZ, Ozhan M. et al FDG PET/CT in monitoring treatment of retroperitoneal fibrosis. Rev Esp Med Nucl Imagen Mol 2012; 31 (06) 338-339 . Epub 2012 May 22
4 Morin G, Mageau A, Benali K. et al Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse. Eur J Intern Med 2019; 62: 67-71 . Epub 2019 Jan 31
5 Moreau A, Giraudet AL, Mognetti T. et al Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18 F]-FDG PET/CT. Eur J Nucl Med Mol Imaging 2019; 46 (08) 1758-1759 . Epub 2019 May 15